Abdul Mannan Explains How DOACs Can Confuse Lupus Anticoagulant Testing
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, has shared a post on LinkedIn:
“Late on a Friday, Dr. Jones reviewed a DRVVT:
• Screen: prolonged
• Mix: no correction
• Confirm: completely normalised
With a confident grin, he declared: ‘Classic Lupus Anticoagulant.’
Diagnosis: Antiphospholipid Syndrome.
Actually, the patient was on rivaroxaban.
The apparent ‘LA’ was nothing more than a DOAC in disguise, and the confirm reagent just happened to mask the culprit.
Moral of the story
Before calling ‘Eureka!’ in the coagulation lab, always check for anticoagulants. DOACs can mimic lupus anticoagulant and mislead even the most confident interpretation.
Learning point
Pre-analytical details are not small print. They are often the hidden plot twists in coagulation testing.”
For more information, check here.
Don’t miss the latest updates with Hemostasis Today.
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin